Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,096 public trials 1,232 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

NCT04309409

Conditions
Malignant Melanoma Stage II, Melanoma, Neoplasms, +10 more
Locations
  • Universitätsklinikum Würzburg - Klinik für Dermatologie, Venerologie und Allergologie Würzburg, Bavaria, Germany
  • Universitätsmedizin Rostock -Klinik und Poliklinik für Dermatologie und Venerologie Rostock, Mecklenburg-Vorpommern, Germany
  • Universitätsklinikum Augsburg, Campus Süd Augsburg, Germany
  • St. Josef-Hospital - Dermatologische Studienambulanz Bochum, Germany
View all 20 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma

NCT04949113

Conditions
Malignant Melanoma Stage III, Melanoma, Neoplasms, +10 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Melanoma Institute Australia (MIA) Sydney, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Australia
View all 24 locations
View Trial Details
Active, Not Recruiting

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

NCT05022901

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Minimal SN Tumor Burden

NCT01942603

Conditions
Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium
  • CHRU de Lille Lille, France
  • CHU de Nice - Hopital De L'Archet Nice, France
  • Institut Gustave Roussy Paris, France
View all 22 locations
View Trial Details
Active, Not Recruiting

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

NCT05270044

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Centro Oncologico Korben CABA, Buenos Aires, Argentina
  • Centro de Investigaciones Medicas Mar del Plata Mar del Plata, Buenos Aires, Argentina
  • Fundacion CIDEA Ciudad Autonoma Bs As, Ciudad Autonoma Buenos Aires, Argentina
  • Sanatorio Britanico S.A. Rosario, Santa Fe Province, Argentina
View all 155 locations
View Trial Details
Active, Not Recruiting

Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)

NCT00626990

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +12 more
Locations
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCSF University of California San Francisco Medical Center-Mount Zion San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
View all 132 locations
View Trial Details

Related conditions